Booth: Country/Region: China Mainland
Beijing BeiLu Pharmaceutical Co.,Ltd. was established in September 1992, mainly engaged in pharmaceutical product development, production and sales. As a high-tech pharmaceutical enterprise jointly identified by the Ministry of Science and Technology, Ministry of Finance and State Administration of Taxation, Beijing BeiLu Pharmaceutical Co.,Ltd. has been committed to the development of universal health, adhering to scientific and technological innovation, creating wealth for the country, contributing to the society, and promoting the growth of enterprise. The company adheres to the business philosophy of "market segment, largest share", clarifying the business development direction in the future. At present, the main products of the company constitute the contrast agent, mental & nerve series and hypoglycemic products. As the first enterprise developed and launched the contrast agents, Beijing BeiLu Pharmaceutical Co.,Ltd. has provided high-quality, safe, reasonably priced products by virtue of technical innovation, process improvement and other measures, giving a significant impetus to the clinical application and development of contrast agent products in China. The company’s products has formed a unique core competitive advantage in this area, enjoying a high visibility and market impact, covering various hospitals above the province, municipality, and county level in China. Beijing BeiLu Pharmaceutical Co.,Ltd. emphasizes on the quality training of marketing staff and the improvement of professional level, gradually establishing a stable, experienced marketing team, in order to better serve doctors and patients.
The Company adheres to the philosophy of people-oriented, strengthening respect, understanding, concern, and care of staff in the management. Cultivating the staff’s corporate responsibility, social responsibility and family responsibility, encouraging the staff to innovate, and hence the Company has formed a stable, harmonious internal environment. In the meanwhile, Beijing BeiLu Pharmaceutical Co.,Ltd. strives to create a unique corporate culture in terms of core values, code of conduct and so forth.
The Company advocates innovation, rigorous style of work, which has made remarkable achievements over the last decade, awarded as A-level Corporate Tax Credit, Zhongguancun Top100 Innovative Pilot Enterprises for many years; won the national invention patents, state-level new product certificate, Beijing Science and Technology Progress Award and other awards; its main products also were included in the national Torch Program, the Beijing Torch Program, Beijing major industrial projects, accessing to all levels of financial support; in 2010, the Company was formally listed in the first-batch scale enterprises of Beijing Biomedical Industry Forward Development Project (G20 Project); in 2010, the Company was named as the " Top 50 Core Competitiveness of Pharmaceutical Listed Enterprises" by the Chinese Academy of Social Sciences, China Medical Information Professional Committee and the industry's leading experts.
On October 30, 2009, the Company publicly listed on the Shenzhen Stock Exchange GEM as one of the first batch of 28 enterprises, indicating that the Company has embarked upon a new historical course and the future holds even brighter prospects. In the future, the Company shall, in virtue of technical innovation, management innovation, professional academic promotion and fund-raising projects, enhance the new drug research and development capabilities, production capacity, operational efficiency, market share and profitability, as well as consolidate and improve the company's core competitiveness.